Biocartis S.a. is a molecular diagnostics company based in Mechelen, Belgium, specializing in the development and commercialization of innovative diagnostic solutions. The company focuses on providing rapid and reliable testing for various diseases, particularly in oncology, through its proprietary Idylla™ platform. This platform enables decentralized testing, allowing healthcare professionals to obtain critical information quickly, thereby enhancing patient management and treatment decisions. Biocartis aims to improve healthcare outcomes by making advanced diagnostics accessible and efficient.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

10 Patents

#5 in Mechelen

#255 in Belgium

#56,047 in the World

Mechelen, Belgium

Biocartis S.a.

Forward Citations = 84

30 inventors:

Michiel De Jong (4 out of 10 patents)

Ronald Cornelis De Gier (3 out of 26 patents)

Marco Van Leeuwen (3 out of 10 patents)

4. Andrea Feuerabend (3 out of 13 patents)

5. Antoinette Van Oeffel (3 out of 3 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Biocartis S.a.. Retrieved from https://idiyas.com/company/biocartis-s-a

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

3 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]